- Question from Lynn: You answered a previous question that confused me! Does hormone-positive breast cancer with chemotherapy have more of an incidence of recurrence than hormone-negative? Thank you!!
- Answers - Marisa Weiss The specific characteristics of a cancer help you and your doctor design the best-tailored treatment plan possible. For women with hormone-receptor-positive breast cancer, usually their greatest benefit will come from hormonal therapy that blocks or decreases the amount of estrogen in your body. If the cancer is hormone-receptor-negative, the medicine treatment that's likely to offer the greatest benefit is chemotherapy. Hormonal therapy has no role. Some women with hormone-receptor-positive cancer may get benefit from chemotherapy in addition to hormonal therapy. There is a test called the Oncotype DX test that analyzes about 21 genes in a cancer. The result can help tell you if you may get additional benefit from adding chemotherapy on top of hormonal therapy. Of course, all of these choices are very individualized so it's important to discuss these issues carefully with your doctor. You may even choose to get a second opinion when you are making a treatment choice as important as chemotherapy.
On Wednesday, December 15, 2010, our Ask-the-Expert Online Conference was called Updates from the 2010 San Antonio Breast Cancer Symposium. Eric Winer, M.D. and Marisa Weiss, M.D. answered your questions about the latest updates on breast cancer risk, screening, and treatment in early and metastatic breast cancer.
The materials presented in these conferences do not necessarily reflect the views of Breastcancer.org. A qualified healthcare professional should be consulted before using any therapeutic product or regimen discussed. All readers should verify all information and data before employing any therapies described here.
A production of LiveWorld, Inc.
Copyright 2010. All rights reserved.